Common Stock SEC Reporting - Delinquent
Pink No Information
Contact Info
  • 121 Gray Avenue
  • Suite 200
  • Santa Barbara, CA 93101

Business Description

Update Company Profile
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2015 10-Q
CIK 0001091326
Fiscal Year End 12/31
OTC Marketplace Pink No Information
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 1995
Employees Not Available
Company Officers/Contacts
Haig Keledijan Founder, VP, Legal
Company Directors
Haig Keledijan Chairman
Arthur Keledjian
Service Providers
Accounting/Auditing Firm
1931 E. 37th Street
Suite 7
Odessa, TX, 79762
United States
JTL Enterprises Corp.
1107 38th Ave.
Seattle, CA, 98122
United States
Securities Counsel
Robert A. Forrester
1755 North Collins Blvd.,
Suite 360
Richardson, TX, 75080
United States
Trombly Business Law, PC OTCQX Sponsor
1434 Spruce Street
Suite 100
Boulder, CO, 80302
United States
Investor Relations Firm

Not Available
Company History
  • Formerly=Viral Genetics, Inc. until 11-2012
  • Note=12-31-03 company is in the development stage, founded to discover, develop and commercialize therapeutic and diagnostic systems for treatment of viral diseases
  • Formerly=5 Star Living Online, Inc. until 11-01
  • Formerly=HiTech Investment, Inc. until 4-99
VGLS Security Details
Share Structure
Market Value1 $1,122,838 a/o Oct 20, 2017
Authorized Shares 170,000,000 a/o Mar 01, 2016
Outstanding Shares 112,283,815 a/o Mar 01, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 63,725,893 a/o Mar 01, 2016
Par Value Not Available
Transfer Agent(s)
Shareholders of Record 157 a/o Mar 01, 2016
Short Selling Data
Short Interest 10,145 (725.47%)
Apr 13, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security